|
ATC Code J02
J02A Antimycotics for systemic use J02AA Antibiotics :J02AA01 Amphotericin B :J02AA02 Hachimycin J02AB Imidazole derivatives :J02AB01 Miconazole :J02AB02 Ketoconazole :QJ02AB90 Clotrimazole J02AC Triazole and tetrazole derivatives :J02AC01 Fluconazole :J02AC02 Itraconazole :J02AC03 Voriconazole :J02AC04 Posaconazole :J02AC05 Isavuconazole :J02AC06 Oteseconazole J02AX Other antimycotics for systemic use :J02AX01 Flucytosine :J02AX04 Caspofungin :J02AX05 Micafungin :J02AX06 Anidulafungin :J02AX07 Ibrexafungerp Ibrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection). It is taken orally (by mouth). It is also currently undergoing clinical trials for other ... :J02AX08 Rezafungin acetate References {{Antifungals J02 ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Antimycotics
An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Such drugs are usually yes obtained by a doctor's prescription, but a few are available over the counter (OTC). Types of antifungal There are two types of antifungals: local and systemic. Local antifungals are usually administered topically or vaginally, depending on the condition being treated. Systemic antifungals are administered orally or intravenously. Of the clinically employed azole antifungals, only a handful are used systemically. These include ketoconazole, itraconazole, fluconazole, fosfluconazole, voriconazole, posaconazole, and isavuconazole. Examples of non-azole systemic antifungals include griseofulvin and terbinafine. Classes Polyenes A polyene is a molecule with multiple conjugated do ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Voriconazole
Voriconazole, sold under the brand name Vfend among others, is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, candidiasis, coccidioidomycosis, histoplasmosis, penicilliosis, and infections by '' Scedosporium'' or ''Fusarium''. It can be taken by mouth or used by injection into a vein. Common side effects include vision problems, nausea, abdominal pain, rash, headache, and seeing or hearing things that are not present. Use during pregnancy may result in harm to the baby. It is in the triazole family of medications. It works by affecting fungal metabolism and fungal cell membranes. Voriconazole was patented in 1990 and approved for medical use in the United States in 2002. It is on the World Health Organization's List of Essential Medicines. Medical uses Voriconazole is used to treat invasive aspergillosis and candidiasis and fungal infections caused by '' Scedosporium'' and ''Fusarium'' species, which may occur in immunocomp ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Ibrexafungerp
Ibrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection). It is taken orally (by mouth). It is also currently undergoing clinical trials for other indications via an intravenous (IV) formulation. An estimated 75% of women will have at least one episode of VVC and 40 to 45% will have two or more episodes in their lifetime. Ibrexafungerp acts via inhibition of glucan synthase, which prevents formation of the fungal cell wall. Ibrexafungerp was approved for medical use in the United States in June 2021. It is the first non-azole oral antifungal drug to be approved by the U.S. Food and Drug Administration (FDA) for the treatment of vaginal yeast infections. The FDA considers it to be a first-in-class medication. Medical uses Ibrexafungerp is indicated for the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC). Ibrexafungerp is currently underg ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Anidulafungin
Anidulafungin (INN) (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366. It may also have application in treating invasive ''Aspergillus'' infection when used in combination with voriconazole. It is a member of the class of antifungal drugs known as the echinocandins; its mechanism of action is by inhibition of (1→3)-β-D-glucan synthase, an enzyme important to the synthesis of the fungal cell wall. It is on the World Health Organization's List of Essential Medicines. Indications * Candidemia and other forms of invasive ''Candida'' infections (intra-abdominal abscess and peritonitis) * Esophageal candidiasis Anidulafungin has not been studied in endocarditis, osteomyelitis, and meningitis due to ''Candida'', and has not been studied in sufficient numbers of neutropenic patients to determine efficacy in this group. Pharmacodynamics and pharmacokinetics Anidulafungin significantly differs from other antifu ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Micafungin
Micafungin, sold under the brand name Mycamine, is an echinochandin antifungal medication used to treat and prevent invasive fungal infections including candidemia, abscesses, and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls that is not found in mammals. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration (FDA) in March 2005, and gained approval in the European Union in April 2008. It is on the ''World Health Organization's List of Essential Medicines''. Indications Micafungin is indicated for the treatment of candidemia, acute disseminated candidiasis, ''Candida'' peritonitis, abscesses and esophageal candidiasis. Since January 23, 2008, micafungin has been approved for the prophylaxis of ''Candida'' infections in patients undergoing hematopoietic stem cell transplantation (HSCT). Micafungin works by way of concentration-dependent inhibition ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Caspofungin
Caspofungin ( INN) (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-glucan synthesis to be approved by the United States Food and Drug Administration. Caspofungin is administered intravenously. It is on the World Health Organization's List of Essential Medicines. Spectrum of Activity Caspofungin has been effective in treating fungal infections caused by ''Aspergillus'' and ''Candida'' species. It is a member of the echinocandin family, a new class of antifungal agents with broad spectrum of activity against all Candida species. In comparison to treatment with either fluconazole or Amphotericin B, all three drugs in this clas ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Flucytosine
Flucytosine, also known as 5-fluorocytosine (5-FC), is an antifungal medication. It is specifically used, together with amphotericin B, for serious ''Candida'' infections and cryptococcosis. It may be used by itself or with other antifungals for chromomycosis. Flucytosine is used by mouth and by injection into a vein. Common side effects include bone marrow suppression, loss of appetite, diarrhea, vomiting, and psychosis. Anaphylaxis and other allergic reactions occasionally occur. It is unclear if use in pregnancy is safe for the baby. Flucytosine is in the fluorinated pyrimidine analogue family of medications. It works by being converted into fluorouracil inside the fungus, which impairs its ability to make protein. Flucytosine was first made in 1957. It is on the World Health Organization's List of Essential Medicines. As of 2016, in the United States the medication cost about US$2,000 per day while in the United Kingdom it is about US$22 per day. It is not available in ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Oteseconazole
Oteseconazole, a novel tetrazole containing orally bioavailable and selective inhibitor of fungal lanosterol 14α-demethylase (CYP51), has shown promising efficacy in the treatment of recurrent vulvovaginal candidiasis (RVVC). Marketed under the brand name Vivjoa, this medication was developed by Mycovia Pharmaceuticals and received approval for medicinal use from United States Food and Drug Administration (US FDA) in April 2022. Society and culture Names Oteseconazole is the international nonproprietary name (INN). Mechanism of action Oteseconazole targets cytochrome P450 enzymes 51 (CYP51), which a play crucial role in maintaining the integrity and growth of fungal cell membranes. Through inhibition of these enzymes, oteseconazole prevents the synthesis of ergosterol, a key component of fungal cell membranes development. This disruption in ergosterol production leads to fungal membranes permeability, ultimately causing cell death. Oteseconazole exhibits selective i ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Isavuconazole
Isavuconazonium sulfate, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis. The most common side effects include abnormal liver tests, nausea, vomiting, difficulty breathing, abdominal pain, diarrhea, injection site reactions, headache, low blood potassium and skin rash. Isavuconazonium is a prodrug of isavuconazole. Medical uses Isavuconazonium is used to treat invasive aspergillosis and invasive mucormycosis in adults aged eighteen years old and older. It is available in a capsule for administration by mouth and as a powder for administration via infusion. Contraindications Isavuconazonium is contraindicated in people taking strong CYP3A4 inhibitors, strong CYP3A4 inducers, or moderate CYP3A4 or CYP3A5 inducers. It is contraindicated in people with familial short QT syndrome. Side effects Common adverse effects (occurring in between 1 and 10% of people) incl ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Posaconazole
Posaconazole, sold under the brand name Noxafil among others, is a triazole antifungal medication. It was approved for medical use in the United States in September 2006, and is available as a generic medication. Medical uses Posaconazole is used to treat invasive ''Aspergillus'' and '' Candida'' infections. It is also used for the treatment of oropharyngeal candidiasis (OPC), including OPC refractory to itraconazole and/or fluconazole therapy. It is also used to treat invasive infections by ''Candida'', ''Mucor'', and ''Aspergillus'' species in severely immunocompromised patients. Clinical evidence for its utility in treatment of invasive disease caused by ''Fusarium'' species ( fusariosis) is limited. It appears to be helpful in a mouse model of naegleriasis. Pharmacology Pharmacodynamics Posaconazole works by disrupting the close packing of acyl chains of phospholipids, impairing the functions of certain membrane-bound enzyme systems such as ATPase and enzymes of ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Itraconazole
Itraconazole, sometimes abbreviated ITZ, is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis. It may be given by mouth or intravenously. Common side effects include nausea, diarrhea, abdominal pain, rash, and headache. Severe side effects may include liver problems, heart failure, Stevens–Johnson syndrome and allergic reactions including anaphylaxis. It is unclear if use during pregnancy or breastfeeding is safe. It is in the triazole family of medications. It stops fungal growth by affecting the cell membrane or affecting their metabolism. Itraconazole was patented in 1978 and approved for medical use in the United States in 1992. It is on the World Health Organization's List of Essential Medicines. Recent research works suggest itraconazole (ITZ) could also be used in the treatment of cancer by inhibiting the hedgehog pathway in a similar way t ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Antibiotic
An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting pathogenic bacteria, bacterial infections, and antibiotic medications are widely used in the therapy, treatment and antibiotic prophylaxis, prevention of such infections. They may either bactericide, kill or bacteriostatic agent, inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics. Sometimes, the term ''antibiotic''—literally "opposing life", from the Greek language, Greek roots ἀντι ''anti'', "against" and βίος ''bios'', "life"—is broadly used to refer to any substance used against microbes, but in the usual medical usage, antibiotics (such as penicillin) are those produced naturally (by one microorgani ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
